RxDoctor Payments Data

Kari Buehler

Psychiatric/Mental Health · Dublin, OHNPI 1164069365

Payments from drug & device makers

$502in general payments, 2019–2025

Across 21 payments — averaging $23.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$112
  • AbbVie$103
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$78
  • Teva Pharmaceuticals USA, Inc.$69
  • Supernus Pharmaceuticals, Inc.$58
  • Lundbeck LLC$51
  • plus $32 from 2 others

What the payments were for

  • Food & beverage$502100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$502 in reported general payments places this provider in the 45th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$6,543
Medicare patients
15
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl32$51,310
TrintellixVortioxetine Hydrobromide12$7,339
Lurasidone Hcl35$6,480
Aripiprazole32$3,046
Bupropion XlBupropion Hcl78$2,160
Vilazodone Hcl20$1,914
Ziprasidone Hcl22$1,776
Buspirone Hcl124$1,565
Doxepin Hcl41$1,074
Prazosin Hcl54$1,036
Venlafaxine Hcl ErVenlafaxine Hcl80$910
Quetiapine Fumarate114$845
Duloxetine Hcl50$798
Oxcarbazepine15$730
Divalproex Sodium ErDivalproex Sodium20$675

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$103$51,31032 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Dublin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →